Evidence map›Paper›PMID 30569596›Full record

ArticleStatistics in medicine2019

Design and analysis considerations for combining data from multiple biomarker studies.

Abigail Sloan, Yue Song, Mitchell H Gail, Rebecca Betensky, Bernard Rosner, Regina G Ziegler, Stephanie A Smith-Warner, Molin Wang

Abstract read
In one paragraph

Article in Statistics in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abigail SloanDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0003-0567-1949
Yue SongDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Mitchell H GailDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Rebecca BetenskyDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Bernard RosnerDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0001-6907-0056
Regina G ZieglerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Stephanie A Smith-WarnerDepartment of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Molin WangDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Funding

Methods for Epidemiology StudiesZIACP010181 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBERT, PAUL · 2009 to 2025
$34.8M
Training in Neurostatistics and NeuroepidemiologyT32NS048005 · NINDS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI ONNELA, JUKKA-PEKKA · 2004 to 2018
$3.2M
Circulating Vitamin D Levels and Risk of Breast and Colorectal Cancer: a Pooled AR01CA152071 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI SMITH-WARNER, STEPHANIE A · 2010 to 2013
$1.4M
Statistical methods for analysis of pooled continuous biomarker data arisen from multiple studiesR03CA212799 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WANG, MOLIN · 2017 to 2018
$159k
NCI NIH HHS R01 CA152071NCI NIH HHS R03 CA212799NINDS NIH HHS T32 NS048005
6 · The paper itself

Abstract

Pooling data from multiple studies improves estimation of exposure-disease associations through increased sample size. However, biomarker exposure measurements can vary substantially across laboratories and often require calibration to a reference assay prior to pooling. We develop two statistical methods for aggregating biomarker data from multiple studies: the full calibration method and the internalized method. The full calibration method calibrates all biomarker measurements regardless of the availability of reference laboratory measurements while the internalized method calibrates only non-reference laboratory measurements. We compare the performance of these two aggregation methods to two-stage methods. Furthermore, we compare the aggregated and two-stage methods when estimating the calibration curve from controls only or from a random sample of individuals from the study cohort. Our findings include the following: (1) Under random sampling for calibration, exposure effect estimates from the internalized method have a smaller mean squared error than those from the full calibration method. (2) Under the controls-only calibration design, the full calibration method yields effect estimates with the least bias. (3) The two-stage approaches produce average effect estimates that are similar to the full calibration method under a controls only calibration design and the internalized method under a random sample calibration design. We illustrate the methods in an application evaluating the relationship between circulating vitamin D levels and stroke risk in a pooling project of cohort studies.

Indexed as

BiomarkersCalibrationData Interpretation, StatisticalResearch DesignAlgorithmsHumansOdds RatioBiomarkersaggregationbetween-study variabilitycalibrationpooling projecttwo-stage method

Identifiers

PMID30569596
PMCPMC6755899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.